在前期性,早期性和中度性帕金森病中,尼格拉体积丧失
medRxiv : the preprint server for health sciences
|August 30, 2023
概括
帕金森病 (PD) 中的黑色神经元损失可以使用磁化转移 (MT) 图像检测. 这项研究表明,黑色色素脱落是一种强大的生物标志物,可用于预发性和明显的PD.
科学领域:
- 神经科学是一个神经科学.
- 放射学 放射学是一门学科.
- 生物标志物 生物标志物
背景情况:
- 帕金森病 (PD) 的特点是黑色质体中黑色神经元 (SNc) 的黑色神经元的损失.
- 磁化转移 (MT) 效应允许在体内可视化这些SNC黑色化神经元.
研究的目的:
- 在帕金森病的各个阶段使用MT成像来调查尼格拉体积变化.
- 评估MT成像作为一种生物标志物用于 prodromal 和 overt PD 中的黑色色素脱落的实用性.
主要方法:
- 使用MT准备的梯度回声序来获取尼格拉尔体积数据.
- 分析了来自对照组,非明显携带者 (LRRK2,GBA1),原发性低血症参与者,快速眼动睡眠行为障碍 (RBD) 患者和来自帕金森病进步标志物倡议的新生/中度PD患者的数据.
主要成果:
- 在对照组和LRRK2/GBA1非显性载体之间没有观察到尼格拉体积的显著差异.
- 在将对照组与前性低血症参与者,RBD参与者和公开的PD患者进行比较时,在nigral体积中发现了显著的群体效应.
结论:
- 通过MT成像检测到的黑色色素脱落,在前兆性和明显的帕金森病中充当了强大的生物标志物.
- 脑电图像显示了早期检测和监测PD神经退行症的潜力.
相关概念视频
Parkinson's Disease: Overview
593
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
593
Parkinson's Disease: Treatment
295
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
295
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Alzheimer's Disease: Overview
517
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
517


